1st Quarter - Report

SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC.

Firm
Client
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Section 520(b) related to custom devices, in the "Food and Drug Administration Safety and Innovation Act," P.L. 112-144. Proposed regulation by the Food and Drug Administration on unique device identifiers.

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist., HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. Medicare competitive bidding for DME.

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist, HHS; Counsel, Sen. Budget Com.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- protect Medical Innovation Act of 2013 Medical device tax amendment to S. Con. Res. 8

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist., HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 523 (113th), S.Con.Res. 8 (113th), S. 232 (113th)

Budget/Appropriations BUD

FY 2013 medical device user fees for the Food and Drug Administration.

LobbyistCovered position, as disclosed
PAUL SELTMAN Spec. Assist., HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.